Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Vannata

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Chinese Clinical Oncology|April 6, 2015
Primary extranodal B-cell lymphoma: current concepts and treatment strategiesBarbara Vannata, Emanuele Zucca
Hematology. American Society of Hematology. Education Program|February 20, 2015
Hepatitis C virus-associated B-cell non-Hodgkin lymphomasBarbara Vannata, Emanuele Zucca
Cancer Treatment and Research|February 7, 2015
Management of the marginal zone lymphomasBarbara Vannata, Anastasios Stathis, Emanuele Zucca
Therapeutic Advances in Hematology|April 8, 2016
Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Barbara Vannata, Luca Arcaini, Emanuele Zucca
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomasEmanuele Zucca, Francesco Bertoni, Barbara Vannata, et al.
Current Opinion in Oncology|July 26, 2022
Bacterial infection-driven lymphomagenesisBarbara Vannata, Maria Cristina Pirosa, Francesco Bertoni, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2013
Mantle cell lymphoma relapsing at the lymphedematous armGiuseppina Massini, Stefan Hohaus, Francesco D'Alò, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
The use of monoclonal antibodies in the treatment of autoimmune complications of chronic lymphocytic leukemiaLuca Laurenti, Barbara Vannata, Idanna Innocenti, et al.
American Journal of Hematology|November 2, 2012
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemiaBarbara Vannata, Idanna Innocenti, Francesco Autore, et al.
Leukemia & Lymphoma|February 17, 2015
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experienceLuca Laurenti, Francesco Autore, Idanna Innocenti, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Chinese Clinical Oncology|April 6, 2015
Primary extranodal B-cell lymphoma: current concepts and treatment strategiesBarbara Vannata, Emanuele Zucca
Hematology. American Society of Hematology. Education Program|February 20, 2015
Hepatitis C virus-associated B-cell non-Hodgkin lymphomasBarbara Vannata, Emanuele Zucca
Cancer Treatment and Research|February 7, 2015
Management of the marginal zone lymphomasBarbara Vannata, Anastasios Stathis, Emanuele Zucca
Therapeutic Advances in Hematology|April 8, 2016
Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Barbara Vannata, Luca Arcaini, Emanuele Zucca
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomasEmanuele Zucca, Francesco Bertoni, Barbara Vannata, et al.
Current Opinion in Oncology|July 26, 2022
Bacterial infection-driven lymphomagenesisBarbara Vannata, Maria Cristina Pirosa, Francesco Bertoni, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2013
Mantle cell lymphoma relapsing at the lymphedematous armGiuseppina Massini, Stefan Hohaus, Francesco D'Alò, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
The use of monoclonal antibodies in the treatment of autoimmune complications of chronic lymphocytic leukemiaLuca Laurenti, Barbara Vannata, Idanna Innocenti, et al.
American Journal of Hematology|November 2, 2012
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemiaBarbara Vannata, Idanna Innocenti, Francesco Autore, et al.
Leukemia & Lymphoma|February 17, 2015
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experienceLuca Laurenti, Francesco Autore, Idanna Innocenti, et al.
Pageof 3